Antigen presentation to cytotoxic T lymphocytes in vivo.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

45 citing papers in PubMed.

1. Primary Sequence-Intrinsic Immune Evasion by Viral Proteins Guides CTL-Based Vaccine Strategies.Viruses · 2025
   Review
2. Targeting Macrophage Polarization for Reinstating Homeostasis following Tissue Damage.International journal of molecular sciences · 2024
   Review
3. Transcription factor Batf3 is important for development of CD8+ T-cell response against a phagosomal bacterium regardless of the location of antigen.Immunology and cell biology · 2016
   Article
4. A combined prediction strategy increases identification of peptides bound with high affinity and stability to porcine MHC class I molecules SLA-1*04:01, SLA-2*04:01, and SLA-3*04:01.Immunogenetics · 2016
   Article
5. Myeloid suppressor cells and immune modulation in lung cancer.Immunotherapy · 2012
   Review
6. Myeloid suppressor cell depletion augments antitumor activity in lung cancer.PloS one · 2012
   Article
7. CD8+ T cells primed in the periphery provide time-bound immune-surveillance to the central nervous system.Journal of immunology (Baltimore, Md. : 1950) · 2011
   Article
8. Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2011
   Article
9. Cancer immunotherapy and nanomedicine.Pharmaceutical research · 2011
   Review
10. CD4+ and CD8+ T cell- and IL-17-mediated protection against Entamoeba histolytica induced by a recombinant vaccine.Vaccine · 2011
    Article
11. Selectively reduced intracellular proliferation of Salmonella enterica serovar typhimurium within APCs limits antigen presentation and development of a rapid CD8 T cell response.Journal of immunology (Baltimore, Md. : 1950) · 2009
    Article
12. Pathogen proliferation governs the magnitude but compromises the function of CD8 T cells.Journal of immunology (Baltimore, Md. : 1950) · 2008
    Article
13. Relative importance of T-cell subsets in monocytotropic ehrlichiosis: a novel effector mechanism involved in Ehrlichia-induced immunopathology in murine ehrlichiosis.Infection and immunity · 2007
    Article
14. A reduced antigen load in vivo, rather than weak inflammation, causes a substantial delay in CD8+ T cell priming against Mycobacterium bovis (bacillus Calmette-Guérin).Journal of immunology (Baltimore, Md. : 1950) · 2007
    Article
15. Delayed expansion and contraction of CD8+ T cell response during infection with virulent Salmonella typhimurium.Journal of immunology (Baltimore, Md. : 1950) · 2006
    Article
16. CD91 up-regulates upon immune stimulation in Xenopus adult but not larval peritoneal leukocytes.Immunogenetics · 2005
    Article
17. Evidence for antibody-mediated enhancement of simian immunodeficiency virus (SIV) Gag antigen processing and cross presentation in SIV-infected rhesus macaques.Journal of virology · 2003
    Article
18. Preexisting inflammation due to Mycobacterium bovis BCG infection differentially modulates T-cell priming against a replicating or nonreplicating immunogen.Infection and immunity · 2002
    Article
19. Immune response induced by airway sensitization after influenza A virus infection depends on timing of antigen exposure in mice.Journal of virology · 2001
    Article
20. Persistent, antigen-specific, therapeutic antitumor immunity by dendritic cells genetically modified with an adenoviral vector to express a model tumor antigen.Gene therapy · 2000
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as